SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Fund Management Regulatory News (JUP)

Share Price Information for Jupiter Fund Management (JUP)

Share Price is delayed by 15 minutes
Get Live Data
176.00    0.00 (0.00%)
Bid:
176.60
Ask:
177.00
Spread: 0.40 (0.227%)
Market Cap: £883.48m
JUP Live PriceLast checked at - London Stock Exchange

Intraday Jupiter Fund Management Share Chart

Stabilisation Notice

22 Apr 2020 09:45

RNS Number : 4905K
J.P. Morgan Securities PLC.
22 April 2020
 

22 Apr 20

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Jupiter Fund Management plc

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

Jupiter Fund Management plc

Guarantor (if any):

N/A

Aggregate nominal amount:

GBP tbc

Description:

GBP 10.25Y Non-Call 5Y Unsecured Unguaranteed Unsubordinated Tier 2 obligations of the Issuer

Listing: London Stock Exchange

Offer price:

TBC

Other offer terms:

Denoms: GBP 100,000 x GBP 1,000

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

 

Stabilisation period expected to start on:

22 Apr 20

Stabilisation period expected to end no later than:

22 May 20

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAEAPLAALDEEEA
Date   Source Headline
6th Mar 20209:00 amRNSDirector Shareholding
4th Mar 20203:40 pmRNSMajor Holdings Notification
3rd Mar 20203:00 pmRNSMajor Holdings Notification
2nd Mar 20204:05 pmRNSDirector Shareholding
28th Feb 20207:00 amRNSResults for the year ended 31 December 2019
17th Feb 20207:00 amRNSAcquisition
17th Feb 20207:00 amRNSResponse to Press Speculation
6th Nov 201910:00 amRNSDirectorate Change
11th Oct 20197:00 amRNSTrading Update and Notice of Results
30th Sep 201912:20 pmRNSDirector/PDMR Shareholding
9th Sep 20193:51 pmRNSDirector/PDMR Shareholding
5th Sep 20199:49 amRNSDirector/PDMR Shareholding
3rd Sep 20194:53 pmRNSConfirmation of appointment of Wayne Mepham
12th Aug 201911:58 amRNSDirector Declaration
12th Aug 201911:23 amRNSMajor Holdings Notification
30th Jul 20197:00 amRNSInterim Report and Accounts
1st Jul 20194:30 pmRNSEuropean Growth Strategy update
20th Jun 20195:04 pmRNSDirector/PDMR Shareholding
10th Jun 20193:48 pmRNSMajor Holdings Notification
30th May 201910:27 amRNSMajor Holdings Notification
16th May 20199:40 amRNSResult of AGM
14th May 20197:00 amRNSDirectorate Change
10th May 201912:31 pmRNSDirector Shareholding
8th May 20194:35 pmRNSDirector Shareholding
1st May 20194:41 pmRNSDirector Shareholding
30th Apr 20197:00 amRNSTrading Update and Notice of Results
17th Apr 20194:31 pmRNSDirector/PDMR Shareholding
16th Apr 20193:30 pmRNSDirector/PDMR Shareholding
10th Apr 20194:28 pmRNSPDMR Shareholding
8th Apr 20192:55 pmRNSDirector/PDMR Shareholding
4th Apr 20192:53 pmRNSPDMR Shareholding
29th Mar 20191:42 pmRNSNotice of Annual General Meeting
25th Mar 201911:27 amRNSPDMR Shareholding
18th Mar 20192:37 pmRNSDirector Shareholding
15th Mar 20193:29 pmRNSPDMR Shareholding
8th Mar 201911:36 amRNSDirector Shareholding
6th Mar 201911:02 amRNSMajor Holdings Notification
5th Mar 201912:25 pmRNSDirector Shareholding
4th Mar 20194:01 pmRNSPDMR Shareholding
4th Mar 201912:26 pmRNSDirector Shareholding
1st Mar 20197:00 amRNSResults for the year ended 31 December 2018
27th Feb 20194:09 pmRNSDirectorate Change Update
26th Feb 20197:00 amRNSDirectorate Change
13th Feb 201910:48 amRNSMajor Holdings Notification
22nd Jan 20197:00 amRNSChief Executive Officer Succession Planning
10th Jan 20197:00 amRNSTrading Update and Notice of Results
18th Dec 20189:48 amRNSPDMR Shareholding
6th Nov 20181:30 pmRNSPDMR Shareholding
2nd Nov 20184:47 pmRNSMajor Holdings Notification
11th Oct 201810:16 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.